Alifrangis C

No ORCID on file · 1 paper in corpus · active 2016
2016
Gynecologic oncology reports ·doi:10.1016/j.gore.2016.11.001

•Case describes a response to sunitinib in clear cell ovarian cancer.•Discussion of unique molecular characteristics of clear cell ovarian cancers•Practical points regarding dosing and toxicity when using sunitinib discussed.